Skip to Content
Home > Care & Treatment > Payson Center for Cancer Care > Clinical Trials > Clinical Trials Search Results
A Randomized Phase II Trial of Neoadjuvant Cisplatin vs Doxorubicin/Cyclophosphamide (AC) in Women with Newly Diagnosed Breast Cancer and Germline BRCA Mutations
This is a two arm Phase III trial in first- and second-line HER2 negative patients with locally recurrent or metastatic breast cancer.
Studying early surgery to see how well it works compared to standard palliative therapy in treating patients with stage IV breast cancer.
For patients with early stage triple negative breast cancer.
This randomized phase III trial studies how well giving hormone therapy together with or without everolimus work in treating patients with breast cancer.
Compare the side effects between trastuzumab emtansine and paclitaxel in combination with trastuzumab. It is believed the trastuzumab emtansine will be lower.
© 2015 Concord Hospital